Preeclampsia, hypoxia, thrombosis, and inflammation

Journal of Pregnancy

Volumn 2012, Issue , 2012, Pages

  Shamshirsaz, Amir A ^a   Paidas, Michael ^a   Krikun, Graciela ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC PROTEIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; CATECHOL METHYLTRANSFERASE; COMPLEMENT;

ANOXIA; CYTOLOGY; ENDOMETRIUM; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; REVIEW; THROMBOSIS;

ANGIOGENIC PROTEINS; ANOXIA; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; CATECHOL O-METHYLTRANSFERASE; COMPLEMENT SYSTEM PROTEINS; ENDOMETRIUM; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFLAMMATION; MATERNAL-FETAL EXCHANGE; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; THROMBOSIS;

EID: 84861344475     PISSN: 20902727     EISSN: 20902735     Source Type: Journal    
DOI: 10.1155/2012/374047     Document Type: Review

References (85)

1. Roccella E. J., Report of the national high blood pressure education program working group on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology 2000 183 1 S1 S22 2-s2.0-0033891361 10.1067/mob.2000.107928 (Pubitemid 30626063)
2. ACOG Committee on Practice Bulletins-Obstetrics, ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstetrics and Gynecology 2002 99 159 167
3. Milne F., Redman C., Walker J., Baker P., Bradley J., Cooper C., De Swiet M., Fletcher G., Jokinen M., Murphy D., Nelson-Piercy C., Osgood V., Robson S., Shennan A., Tuffnell A., Twaddle S., Waugh J., The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. British Medical Journal 2005 330 7491 576 580 2-s2.0-20144367499 (Pubitemid 40380353)
4. Sibai B. M., Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. American Journal of Obstetrics and Gynecology 2004 190 6 1520 1526 2-s2.0-3442901384 10.1016/j.ajog.2003.12.057 (Pubitemid 39006184)
5. Berg C. J., MacKay A. P., Qin C., Callaghan W. M., Overview of maternal morbidity during hospitalization for labor and delivery in the united states: 19931997 and 20012005. Obstetrics and Gynecology 2009 113 5 1075 1081 2-s2.0-66149094693 10.1097/AOG.0b013e3181a09fc0
6. Ogden C. L., Carroll M. D., Curtin L. R., McDowell M. A., Tabak C. J., Flegal K. M., Prevalence of overweight and obesity in the United States, 19992004. Journal of the American Medical Association 2006 295 13 1549 1555 2-s2.0-33645523067 10.1001/jama.295.13.1549
7. Catov J. M., Ness R. B., Kip K. E., Olsen J., Risk of early or severe preeclampsia related to pre-existing conditions. International Journal of Epidemiology 2007 36 2 412 419 2-s2.0-34447302621 10.1093/ije/dyl271 (Pubitemid 47064330)
8. Duley L., rcrt@ndm.ox.ac.uk Pre-eclampsia and the hypertensive disorders of pregnancy. British Medical Bulletin 2003 67 161 176 10.1093/bmb/ldg005 (Pubitemid 38111999)
9. Khan K. S., Wojdyla D., Say L., Gülmezoglu A. M., Van Look P. F., WHO analysis of causes of maternal death: a systematic review. Lancet 2006 367 9516 1066 1074 2-s2.0-33645737208 10.1016/S0140-6736(06)68397-9
10. Lykke J. A., Langhoff-Roos J., Sibai B. M., Funai E. F., Triche E. W., Paidas M. J., Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009 53 6 944 951 2-s2.0-67049118952 10.1161/HYPERTENSIONAHA.109.130765
11. Roberts J. M., Hubel C. A., The two stage model of preeclampsia: variations on the theme. Placenta 2009 30 S32 S37 2-s2.0-60249089098 10.1016/j.placenta.2008.11.009
12. Steegers E. A. P., von Dadelszen P., Duvekot J. J., Pijnenborg R., Pre-eclampsia. The Lancet 2010 376 9741 631 644 2-s2.0-77956061313 10.1016/S0140-6736(10)60279-6
13. Levine R. J., Lam C., Qian C., Yu K. F., Maynard S. E., Sachs B. P., Sibai B. M., Epstein F. H., Romero R., Thadhani R., Karumanchi S. A., Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New England Journal of Medicine 2006 355 10 992 1005 2-s2.0-33748421660 10.1056/NEJMoa055352 (Pubitemid 44343543)
14. Vuorela P., Helske S., Hornig C., Alitalo K., Weich H., Halmesmaki E., Amniotic fluidsoluble vascular endothelial growth factor receptor-1 in preeclampsia. Obstetrics & Gynecology 2000 95 353 357 (Pubitemid 30100498)
15. Rajakumar A., Michael H. M., Rajakumar P. A., Shibata E., Hubel C. A., Ananth Karumanchi S., Thadhani R., Wolf M., Harger G., Markovic N., Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 2005 26 7 563 573 2-s2.0-21444452423 10.1016/j.placenta.2004.09.001 (Pubitemid 40916309)
16. Maynard S. E., Min J. Y., Merchan J., Lim K. H., Li J., Mondal S., Libermann T. A., Morgan J. P., Sellke F. W., Stillman I. E., Epstein F. H., Sukhatme V. P., Karumanchi S. A., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction hypertension, and proteinuria in preeclampsia. Journal of Clinical Investigation 2003 111 5 649 658 2-s2.0-0037373006 10.1172/JCI200317189 (Pubitemid 36278583)
17. Mutter W. P., Karumanchi S. A., sananth@bidmc.harvard.edu Molecular mechanisms of preeclampsia. Microvascular Research 2008 75 1 1 8 10.1016/j.mvr.2007.04.009 (Pubitemid 350266733)
18. Baumwell S., Karumanchi S. A., Pre-eclampsia: clinical manifestations and molecular mechanisms. NephronClinical Practice 2007 106 2 c72 c81 2-s2.0-34250676880 10.1159/000101801 (Pubitemid 46933395)
19. Venkatesha S., Toporsian M., Lam C., Hanai J. I., Mammoto T., Kim Y. M., Bdolah Y., Lim K. H., Yuan H. T., Libermann T. A., Stillman I. E., Roberts D., D'Amore P. A., Epstein F. H., Sellke F. W., Romero R., Sukhatme V. P., Letarte M., Karumanchi S. A., Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Medicine 2006 12 6 642 649 2-s2.0-33744985816 10.1038/nm1429 (Pubitemid 43865232)
20. Gilbert J. S., Ryan M. J., Lamarca B. B., Sedeek M., Murphy S. R., Granger J. P., Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. American Journal of PhysiologyHeart and Circulatory Physiology 2008 294 2 H541 H550 2-s2.0-39149111944 10.1152/ajpheart.01113.2007 (Pubitemid 351253261)
21. Karumanchi S. A., Lindheimer M. D., Preeclampsia pathogenesis: Triple a rating-autoantibodies and antiAngiogenic factors. Hypertension 2008 51 4 991 992 2-s2.0-40849100423 10.1161/HYPERTENSIONAHA.107.100735 (Pubitemid 351398952)
22. Wang A., Rana S., Karumanchi S. A., Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology 2009 24 3 147 158 2-s2.0-67649227647 10.1152/physiol.00043.2008
23. Zhu B. T., Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and kenobiotics: importance in pathophysiology and pathogenesis. Current Drug Metabolism 2002 3 3 321 349 2-s2.0-0035987204 10.2174/1389200023337586 (Pubitemid 34625043)
24. Mooberry S. L., Mechanism of action of 2-methoxyestradiol: new developments. Drug Resistance Updates 2003 6 6 355 361 2-s2.0-0842269204 10.1016/j.drup.2003.10.001 (Pubitemid 38173586)
25. Mabjeesh N. J., Escuin D., LaVallee T. M., Pribluda V. S., Swartz G. M., Johnson M. S., Willard M. T., Zhong H., Simons J. W., Giannakakou P., 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003 3 4 363 375 2-s2.0-10744231706 10.1016/S1535-6108(03)00077-1 (Pubitemid 38340305)
26. Kanasaki K., Palmsten K., Sugimoto H., Ahmad S., Hamano Y., Xie L., Parry S., Augustin H. G., Gattone V. H., Folkman J., Strauss J. F., Kalluri R., Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008 453 7198 1117 1121 2-s2.0-45749098246 10.1038/nature06951 (Pubitemid 351871733)
27. Barchiesi F., Jackson E. K., Gillespie D. G., Zacharia L. C., Fingerle J., Dubey R. K., Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCS. Hypertension 2002 39 4 874 879 2-s2.0-0036232439 10.1161/01.HYP.0000013863.25970.BA (Pubitemid 34437542)
28. Lee S. B., Wong A. P., Kanasaki K., Xu Y., Shenoy V. K., McElrath T. F., Whitesides G. M., Kalluri R., Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions. American Journal of Pathology 2010 176 2 710 720 2-s2.0-76149146741 10.2353/ajpath.2010.090513
29. Holers V. M., The spectrum of complement alternative pathway-mediated diseases. Immunological Reviews 2008 223 1 300 316 2-s2.0-47249120139 10.1111/j.1600-065X.2008.00641.x (Pubitemid 351986186)
30. Imrie H. J., McGonigle T. P., Liu D. T. Y., Jones D. R. E., Reduction in erythrocyte complement receptor 1 (CR1, CD35) and decay accelerating factor (DAF, CD55) during normal pregnancy. Journal of Reproductive Immunology 1996 31 3 221 227 2-s2.0-0030271621 10.1016/0165-0378(96)00977-1 (Pubitemid 26341230)
31. Abramson S. B., Buyon J. P., Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy. American Journal of Reproductive Immunology 1992 28 3-4 183 187 2-s2.0-0027082674 (Pubitemid 23044826)
32. Sinha D., Wells M., Page Faulk W., Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi. Clinical and Experimental Immunology 1984 56 1 175 184 2-s2.0-0021359052 (Pubitemid 14161203)
33. Lynch A. M., anne.lynch@uchsc.edu Murphy J. R., Byers T., Gibbs R. S., Neville M. C., Giclas P. C., Salmon J. E., Holers V. M., Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. American Journal of Obstetrics and Gynecology 2008 198 4 385.e1 385.e9 10.1016/j.ajog.2007.10.793
34. Tedesco F., Radillo O., Candussi G., Nazzaro A., Mollnes T. E., Pecorari D., Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae. Clinical and Experimental Immunology 1990 80 2 236 240 2-s2.0-0025259785 (Pubitemid 20147722)
35. Labarrere C., Mullen E., Fibrinoid and trophoblastic necrosis with massive chronic intervillositis: an extreme variant of villitis of unknown etiology. American Journal of Reproductive Immunology and Microbiology 1987 15 3 85 91 (Pubitemid 18022899)
36. Rampersad R., Barton A., Sadovsky Y., Nelson D. M., The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro. Placenta 2008 29 10 855 861 2-s2.0-51249107095 10.1016/j.placenta.2008.07.008
37. Girardi G., Bulla R., Salmon J. E., Tedesco F., The complement system in the pathophysiology of pregnancy. Molecular Immunology 2006 43 1-2 68 77 2-s2.0-22544486255 10.1016/j.molimm.2005.06.017 (Pubitemid 41021523)
38. Tedesco F., Narchi G., Radillo O., Meri S., Ferrone S., Betterle C., Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. Journal of Immunology 1993 151 3 1562 1570 2-s2.0-0027305407 (Pubitemid 23219294)
39. Salmon J. E., salmonj@hss.edu Heuser C., Triebwasser M., Liszewski M. K., Kavanagh D., Roumenina L., Branch D. W., Goodship T., Fremeaux-Bacchi V., Atkinson J. P., Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Medicine 2011 8 3 10.1371/journal.pmed.1001013 e1001013
40. Krikun G., Huang S. T. J., Schatz F., Salafia C., Stocco C., Lockwood C. J., Thrombin activation of endometrial endothelial cells: a possible role in intrauterine growth restriction. Thrombosis and Haemostasis 2007 97 2 245 253 2-s2.0-33947537198 10.1160/TH06-07-0387 (Pubitemid 46592145)
41. Hustin J., Foidart J. M., Lambotte R., Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: light microscopy and immunofluorescence. Placenta 1983 4 489 498 2-s2.0-0021040375 (Pubitemid 14150209)
42. Papageorghiou A. T., Roberts N., Uterine artery Doppler screening for adverse pregnancy outcome. Current Opinion in Obstetrics and Gynecology 2005 17 6 584 590 2-s2.0-27844532531 (Pubitemid 41658964)
43. Procházková J., prochazkovajana@hotmail.com Pilka R., Měchurová A., Šimetka O., Brychtová P., Procházka M., Endotelial activation markerspossibilities of their detection and clinical signification in gynaecology and obstetric. Ceska Gynekologie 2009 74 4 279 281
44. Sheppard B. L., Bonnar J., An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. British Journal of Obstetrics and Gynaecology 1981 88 7 695 705 2-s2.0-0019453778 (Pubitemid 11052966)
45. Levi M., van der Poll T., ten Cate H., Tissue factor in infection and severe inflammation. Seminars in Thrombosis and Hemostasis 2006 32 33 39
46. Grau V., Stehling O., Garn H., Steiniger B., Accumulating monocytes in the vasculature of rat renal allografts: phenotype, cytokine, inducible no synthase, and tissue factor mRNA expression. Transplantation 2001 71 1 37 46 2-s2.0-0035863240 (Pubitemid 32105776)
47. Tilley R., Mackman N., Tissue factor in hemostasis and thrombosis. Seminars in Thrombosis and Hemostasis 2006 35 5 10
48. Fei H., Berliner J. A., Parhami F., Drake T. A., Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arteriosclerosis and Thrombosis 1993 13 11 1711 1717 2-s2.0-0027381488 (Pubitemid 23328492)
49. Hölschermann H., Bohle R. M., Zeller H., Schmidt H., Stahl U., Fink L., Grimm H., Tillmanns H., Haberbosch W., In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy. American Journal of Pathology 1999 154 1 211 220 2-s2.0-0345471355 (Pubitemid 29031628)
50. Stallmach T., Hebisch G., Orban P., Lü X., Aberrant positioning of trophoblast and lymphocytes in the feto-maternal interface with pre-eclampsia. Virchows Archiv 1999 434 3 207 211 2-s2.0-0032891536 10.1007/s004280050329 (Pubitemid 29186804)
51. Di Paolo S., Volpe P., Grandaliano G., Stallone G., Schena A., Greco P., Resta L., Selvaggi L., Cincione R., Schena F. P., Gesualdo L., Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. Journal of Nephrology 2003 16 5 650 657 2-s2.0-1442282935 (Pubitemid 38714248)
52. Lockwood C. J., Krikun G., Schatz F., The decidua regulates hemostasis in human endometrium. Seminars in Reproductive Endocrinology 1999 17 1 45 51 (Pubitemid 29293552)
53. Lockwood C. J., Krikun G., Papp C., Toth-Pal E., Markiewicz L., Wang E. Y., Kerenyi T., Zhou X., Hausknecht V., Papp Z., Schatz F., The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation. Annals of the New York Academy of Sciences 1994 734 57 79 2-s2.0-0028656430 10.1111/j.1749-6632.1994.tb21736.x
54. Erlich J., Parry G. C. N., Fearns C., Muller M., Carmeliet P., Luther T., Mackman N., Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proceedings of the National Academy of Sciences of the United States of America 1999 96 14 8138 8143 2-s2.0-0033529280 10.1073/pnas.96.14.8138 (Pubitemid 29328421)
55. Labarrere C. A., Faulk W. P., Anchoring villi in human placental basal plate: lymphocytes, macrophages and coagulation. Placenta 1991 12 2 173 182 2-s2.0-0025726490
56. Uszynski M., Ekanowska E., Uszynski W., Kuczynski J., Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. European Journal of Obstetrics Gynecology and Reproductive Biology 2001 95 2 163 166 10.1016/S0301-2115(00)00448-6 (Pubitemid 32297709)
57. Lockwood C. J., Bach R., Guha A., Zhou X., Miller W. A., Nemerson Y., Amniotic fluid contains tissue factor, a potent initiator of coagulation. American Journal of Obstetrics and Gynecology 1991 165 5 I 1335 1341 2-s2.0-0025939802
58. Poredos P., Jezovnik M. K., The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis. International Angiology 2007 26 4 306 311 2-s2.0-38949104392 (Pubitemid 351227733)
59. Tesselaar M. E., Osanto S., Risk of venous thromboembolism in lung cancer. Current Opinion in Pulmonary Medicine 2007 13 5 362 367 2-s2.0-34748888394 10.1097/MCP.0b013e328209413c (Pubitemid 47472294)
60. Keenan C. R., Murin S., White R. H., High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses. Journal of Thrombosis and Haemostasis 2007 5 6 1185 1190 2-s2.0-34250191135 10.1111/j.1538-7836.2007.02553.x (Pubitemid 46902120)
61. Uno K., Homma S., Satoh T., Nakanishi K., Abe D., Matsumoto K., Oki A., Tsunoda H., Yamaguchi I., Nagasawa T., Yoshikawa H., Aonuma K., Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. British Journal of Cancer 2007 96 2 290 295 2-s2.0-33846498353 10.1038/sj.bjc.6603552 (Pubitemid 46164734)
62. Yap K. P. L., McCready D. R., Deep vein thrombosis and malignancy: a surgical oncologist's perspective. Asian Journal of Surgery 2004 27 3 249 254 2-s2.0-4143090339 (Pubitemid 39094907)
63. Sambola A., Osende J., Hathcock J., Degen M., Nemerson Y., Fuster V., Crandall J., Badimon J. J., Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 2003 107 7 973 977 2-s2.0-0037465510 10.1161/01.CIR.0000050621.67499.7D (Pubitemid 36258719)
64. Hron G., Kollars M., Weber H., Sagaster V., Quehenberger P., Eichinger S., Kyrle P. A., Weltermann A., Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thrombosis and Haemostasis 2007 97 1 119 123 2-s2.0-33846941576 10.1160/TH06-03-0141 (Pubitemid 46242392)
65. Osterud B., Bjorklid E., The tissue factor pathway in disseminated intravascular coagulation. Seminars in Thrombosis and Hemostasis 2001 27 6 605 617 10.1055/s-2001-18866 (Pubitemid 33152573)
66. osterud B., Bjarne.Osterud@fagmed.uit.no Bjorklid E., Sources of tissue factor. Seminars in Thrombosis and Hemostasis 2006 32 1 11 23
67. Rauch U., Nemerson Y., Circulating tissue factor and thrombosis. Current Opinion in Hematology 2000 7 5 273 277 2-s2.0-0033900083 10.1097/00062752- 200009000-00003 (Pubitemid 30637665)
68. Rousseau A., Favier R., Van Dreden P., pvandreden@stago.fr Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? European Journal of Obstetrics Gynecology and Reproductive Biology 2009 146 1 46 49 10.1016/j.ejogrb.2009.06.001
69. Biró E., Sturk-Maquelin K. N., Vogel G. M., Meuleman D. G., Smit M. J., Hack C. E., Sturk A., Nieuwland R., Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. Journal of Thrombosis and Haemostasis 2003 1 12 2561 2568 2-s2.0-1442285353
70. Brenner B., Haemostatic changes in pregnancy. Thrombosis Research 2004 114 5-6 409 414 2-s2.0-7044249206 10.1016/j.thromres.2004.08.004 (Pubitemid 39422573)
71. Goswamia D., Tannetta D. S., Magee L. A., Fuchisawa A., Redman C. W. G., Sargent I. L., von Dadelszen P., Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006 27 1 56 61 2-s2.0-27944467137 10.1016/j.placenta.2004.11.007 (Pubitemid 41662880)
72. Greer I. A., Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999 353 9160 1258 1265 2-s2.0-0033541493 10.1016/S0140-6736(98)10265-9 (Pubitemid 29168473)
73. Pabinger I., Grafenhofer H., Kaider A., Ilic A., Eichinger S., Quehenberger P., Husslein P., Mannhalter C., Lechner K., Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 5 874 879 2-s2.0-0035038413 (Pubitemid 32448783)
74. Holmes V. A., Wallace J. M., Haemostasis in normal pregnancy: a balancing act? Biochemical Society Transactions 2005 33 2 428 432 2-s2.0-18044384109 10.1042/BST0330428 (Pubitemid 40604387)
75. Hellgren M., margareta.hellgren@vgregien.se Hemostasis during normal pregnancy and puerperlum. Seminars in Thrombosis and Hemostasis 2003 29 2 125 130 10.1055/s-2003-38897 (Pubitemid 36458191)
76. Lockwood C. J., Murk W., Kayisli U. A., Buchwalder L. F., Huang S. T., Funai E. F., Krikun G., Schatz F., Progestin and thrombin regulate tissue factor expression in human term decidual cells. Journal of Clinical Endocrinology and Metabolism 2009 94 6 2164 2170 2-s2.0-66749134695 10.1210/jc.2009-0065
77. Lockwood C. J., Nemerson Y., Krikun G., Hausknecht V., Markiewicz L., Alvarez M., Guller S., Schatz F., Steroid-modulated stromal cell tissue factor expression: a model for the regulation of endometrial hemostasis and menstruation. Journal of Clinical Endocrinology and Metabolism 1993 77 4 1014 1019 2-s2.0-0027439126 10.1210/jc.77.4.1014 (Pubitemid 23301479)
78. Lockwood C. J., Nemerson Y., Guller S., Krikun G., Alvarez M., Hausknecht V., Gurpide E., Schatz F., Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. Journal of Clinical Endocrinology and Metabolism 1993 76 1 231 236 2-s2.0-0027391614 10.1210/jc.76.1.231 (Pubitemid 23027585)
79. Krikun G., Lockwood C. J., Paidas M. J., Tissue factor and the endometrium: from physiology to pathology. Thrombosis Research 2009 124 4 393 396 2-s2.0-69249230822 10.1016/j.thromres.2009.06.013
80. Wang Y., Gu Y., Zhang Y., Lewis D. F., Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. American Journal of Obstetrics and Gynecology 2004 190 3 817 824 2-s2.0-1642505527 10.1016/j.ajog.2003.09.049 (Pubitemid 38406799)
81. Matta P., Lockwood C. J., Schatz F., Krikun G., Rahman M., Buchwalder L., Norwitz E. R., errol.norwitz@yale.edu Thrombin regulates monocyte chemoattractant protein-1 expression in human first trimester and term decidual cells. American Journal of Obstetrics and Gynecology 2007 196 3 268.e1 268.e8 10.1016/j.ajog.2006.09.008 (Pubitemid 46341189)
82. Lockwood C. J., Huang S. J., Krikun G., Caze R., Rahman M., Buchwalder L. F., Schatz F., frederick.schatz@yale.edu Decidual hemostasis, inflammation, and angiogenesis in pre-eclampsia. Seminars in Thrombosis and Hemostasis 2011 37 2 158 164 10.1055/s-0030-1270344
83. Abrahams V. M., Kim Y. M., Straszewski S. L., Romero R., Mor G., Macrophages and apoptotic cell clearance during pregnancy. American Journal of Reproductive Immunology 2004 51 4 275 282 2-s2.0-1842470945 (Pubitemid 38455729)
84. Reister F., Frank H. G., Kingdom J. C. P., Heyl W., Kaufmann P., Rath W., Huppertz B., Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Laboratory Investigation 2001 81 8 1143 1152 2-s2.0-0034883831 (Pubitemid 32772074)
85. Scazzocchio E., Figueras F., ffiguera@clinic.ub.es Contemporary prediction of preeclampsia. Current Opinion in Obstetrics and Gynecology 2011 23 2 65 71 10.1097/GCO.0b013e328344579c